Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI
- PMID: 34003350
- DOI: 10.1007/s00330-021-08044-z
Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI
Abstract
Objective: This study aimed to evaluate whether arterial input functions (AIFs) obtained from dynamic susceptibility contrast (DSC)-MRI (AIFDSC) improve the reliability and diagnostic accuracy of dynamic contrast-enhanced (DCE)-derived pharmacokinetic (PK) parameters for differentiating glioblastoma from primary CNS lymphoma (PCNSL) compared with AIFs derived from DCE-MRI (AIFDCE).
Methods: This retrospective study included 172 patients with glioblastoma (n = 147) and PCNSL (n = 25). All patients had undergone preoperative DSC- and DCE-MRI. The volume transfer constant (Ktrans), volume of the vascular plasma space (vp), and volume of the extravascular extracellular space (ve) were acquired using AIFDSC and AIFDCE. The relative cerebral blood volume (rCBV) was obtained from DSC-MRI. Intraclass correlation coefficients (ICC) and ROC curves were used to assess the reliability and diagnostic accuracy of individual parameters.
Results: The mean Ktrans, vp, and ve values revealed better ICCs with AIFDSC than with AIFDCE (Ktrans, 0.911 vs 0.355; vp, 0.766 vs 0.503; ve, 0.758 vs 0.657, respectively). For differentiating all glioblastomas from PCNSL, the mean rCBV (AUC = 0.856) was more accurate than the AIFDSC-driven mean Ktrans, which had the largest AUC (0.711) among the DCE-derived parameters (p = 0.02). However, for glioblastomas with low rCBV (≤ 75th percentile of PCNSL; n = 30), the AIFDSC-driven mean Ktrans and vp were more accurate than rCBV (AUC: Ktrans, 0.807 vs rCBV, 0.515, p = 0.004; vp, 0.715 vs rCBV, p = 0.045).
Conclusion: DCE-derived PK parameters using the AIFDSC showed improved reliability and diagnostic accuracy for differentiating glioblastoma with low rCBV from PCNSL.
Key points: • An accurate differential diagnosis of glioblastoma and PCNSL is crucial because of different therapeutic strategies. • In contrast to the rCBV from DSC-MRI, another perfusion imaging technique, the DCE parameters for the differential diagnosis have been limited because of the low reliability of AIFs from DCE-MRI. • When we analyzed DCE-MRI data using AIFs from DSC-MRI (AIFDSC), AIFDSC-driven DCE parameters showed improved reliability and better diagnostic accuracy than rCBV for differentiating glioblastoma with low rCBV from PCNSL.
Keywords: Diagnostic imaging; Glioblastoma; Lymphoma; Magnetic resonance imaging; Perfusion imaging.
© 2021. European Society of Radiology.
Similar articles
-
Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.Radiology. 2018 Mar;286(3):981-991. doi: 10.1148/radiol.2017170764. Epub 2017 Dec 15. Radiology. 2018. PMID: 29244617
-
Improving the Reliability of Pharmacokinetic Parameters at Dynamic Contrast-enhanced MRI in Astrocytomas: A Deep Learning Approach.Radiology. 2020 Oct;297(1):178-188. doi: 10.1148/radiol.2020192763. Epub 2020 Aug 4. Radiology. 2020. PMID: 32749203
-
Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.Eur J Radiol. 2016 Jun;85(6):1147-56. doi: 10.1016/j.ejrad.2016.03.020. Epub 2016 Mar 22. Eur J Radiol. 2016. PMID: 27161065
-
MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.J Magn Reson Imaging. 2019 Aug;50(2):560-572. doi: 10.1002/jmri.26602. Epub 2019 Jan 14. J Magn Reson Imaging. 2019. PMID: 30637843
-
Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.Neuroimage Clin. 2018 Jul 5;20:51-60. doi: 10.1016/j.nicl.2018.07.001. eCollection 2018. Neuroimage Clin. 2018. PMID: 30069427 Free PMC article. Review.
Cited by
-
Construction and imaging of a neurovascular unit model.Neural Regen Res. 2022 Aug;17(8):1685-1694. doi: 10.4103/1673-5374.332131. Neural Regen Res. 2022. PMID: 35017415 Free PMC article. Review.
-
Improving measurement of blood-brain barrier permeability with reduced scan time using deep-learning-derived capillary input function.Neuroimage. 2023 Sep;278:120284. doi: 10.1016/j.neuroimage.2023.120284. Epub 2023 Jul 26. Neuroimage. 2023. PMID: 37507078 Free PMC article.
-
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma.Neurooncol Adv. 2023 Oct 18;5(1):vdad136. doi: 10.1093/noajnl/vdad136. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 38024240 Free PMC article.
-
Distinctive magnetic resonance imaging features in primary central nervous system lymphoma: A case report.World J Radiol. 2023 Sep 28;15(9):274-280. doi: 10.4329/wjr.v15.i9.274. World J Radiol. 2023. PMID: 37823021 Free PMC article.
-
Review of tracer kinetic models in evaluation of gliomas using dynamic contrast-enhanced imaging.Front Oncol. 2024 Jun 14;14:1380793. doi: 10.3389/fonc.2024.1380793. eCollection 2024. Front Oncol. 2024. PMID: 38947892 Free PMC article. Review.
References
-
- Al-Okaili RN, Krejza J, Woo JH et al (2007) Intraaxial brain masses: MR imaging–based diagnostic strategy—initial experience. Radiology 243:539–550 - PubMed
MeSH terms
Substances
Grants and funding
- HI16C1111/Key Technology Research and Development Program of Shandong (CN)
- NRF-2016M3C7A1914002/National Research Foundation of Korea
- NRF-2020R1A2C2008949/National Research Foundation of Korea
- NRF-2019K1A3A1A77079379/National Research Foundation of Korea
- NRF-2017R1A2B2008412/National Research Foundation of Korea
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical